isoliquiritigenin

Isoliquiritigenin is a lipid of Polyketides (PK) class. Isoliquiritigenin is associated with abnormalities such as abnormal fragmented structure, Gastric ulcer, Gastric mucosa lesion, Peptic Ulcer and Wiskott-Aldrich Syndrome. The involved functions are known as Mass-to-Charge Ratio, Anabolism, Oxidation, inhibitors and Energy Absorption. Isoliquiritigenin often locates in Microsomes, Liver, Hepatic, Microsomes, Immune system and Vacuole. The associated genes with Isoliquiritigenin are P4HTM gene, BCL2 gene, AP1AR gene, oxytocin, 1-desamino-(O-Et-Tyr)(2)- and ODAM gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of isoliquiritigenin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with isoliquiritigenin?

isoliquiritigenin is suspected in Gastric mucosa lesion, Gastric ulcer, Peptic Ulcer, Nodule, Infertility and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with isoliquiritigenin

MeSH term MeSH ID Detail
Carcinoma, Adenoid Cystic D003528 3 associated lipids
Choroidal Neovascularization D020256 5 associated lipids
Leiomyoma D007889 8 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Precancerous Conditions D011230 48 associated lipids
Weight Loss D015431 56 associated lipids
Glioma D005910 112 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with isoliquiritigenin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with isoliquiritigenin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with isoliquiritigenin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with isoliquiritigenin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with isoliquiritigenin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with isoliquiritigenin?

Knock-out

Knock-out are used in the study 'Two activators of in vitro fertilization in mice from licorice.' (Tung NH et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with isoliquiritigenin

Download all related citations
Per page 10 20 50 100 | Total 275
Authors Title Published Journal PubMed Link
Yang EJ et al. Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction. 2012 Biochem. Biophys. Res. Commun. pmid:22538371
Shi Y et al. Analgesic and uterine relaxant effects of isoliquiritigenin, a flavone from Glycyrrhiza glabra. 2012 Phytother Res pmid:22389128
Srinivasan B et al. Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies. 2011 Bioorg. Med. Chem. Lett. pmid:21112783
Kawakami Z et al. Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan. 2011 Cell. Mol. Neurobiol. pmid:21691759
Birari RB et al. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies. 2011 Phytomedicine pmid:21315569
Han B et al. Determination of isoliquiritigenin and its distribution in mice by synchronous fluorescence spectrometry. 2011 Anal Sci pmid:22076338
Yang H et al. Isoliquiritigenin (4,2',4'-trihydroxychalcone): a new matrix-assisted laser desorption/ionization matrix with outstanding properties for the analysis of neutral oligosaccharides. 2011 Anal. Chim. Acta pmid:21763807
Feldman M et al. Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential. 2011 J. Nat. Prod. pmid:21866899
Cui FC et al. Elucidation of the methyl transfer mechanism catalyzed by chalcone O-methyltransferase: a density functional study. 2011 J Comput Chem pmid:21815175
Jhanji V et al. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models. 2011 Br J Ophthalmol pmid:21719569
Sano S et al. Reinvestigation of the synthesis of isoliquiritigenin: application of Horner-Wadsworth-Emmons reaction and Claisen-Schmidt condensation. 2011 Chem. Pharm. Bull. pmid:21720042
Cho S et al. Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABAA receptors and shows hypnotic effects. 2011 Biochem. Biophys. Res. Commun. pmid:21945440
Thiyagarajan P et al. Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents. 2011 Inflammopharmacology pmid:21328091
Chandrasekaran CV et al. Dual inhibitory effect of Glycyrrhiza glabra (GutGardâ„¢) on COX and LOX products. 2011 Phytomedicine pmid:20864324
Youns M et al. Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics. 2010 Naunyn Schmiedebergs Arch. Pharmacol. pmid:20668838
Sun ZJ et al. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. 2010 J. Pharmacol. Exp. Ther. pmid:20484154
Zhang X et al. Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. 2010 Clin. Exp. Pharmacol. Physiol. pmid:20456427
Li J et al. Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation. 2010 J. Agric. Food Chem. pmid:20146476
Cuendet M et al. Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice. 2010 Cancer Prev Res (Phila) pmid:20068129
Lau GT et al. The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line. 2010 Planta Med. pmid:20033868